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1 Abstract 15 
Stx bacteriophages are members of the lambdoid group of phages and are responsible for Shiga toxin 16 
(Stx) production and the dissemination of Shiga toxin genes (stx) across shigatoxigenic E. coli 17 
(STEC). These toxigenic bacteriophage hosts can cause life-threatening illness, and Shiga toxin (Stx) 18 
is the virulence determinant responsible for the severe nature of infection with enterohemorrhagic E. 19 
coli (EHEC), a subset of pathogenic STEC. Stx phages are temperate, and in the present study the 20 
identification of what is actually required for Stx phage Φ24B and bacterial DNA recombination was 21 
tested using both in vitro and in situ recombination assays. It is well established that phage , which 22 
underpins most of what we understand about lambdoid phage biology, requires its own encoded 23 
phage attachment site (attP) of 250 bp, a host encoded attachment site (attB) of 21 bp and a host 24 
encoded, DNA binding protein known as integration host factor (IHF). The assays applied in this 25 
study enabled the manipulation of the phage attachment site (attP) and bacterial attachment site 26 
(attB) sequences, and the inclusion or exclusion of a host-encoded accessory element known as 27 
integration host factor.  We were able to demonstrate that the minimal attP sequence required by 28 
Φ24B phage is between 350 and 427 bp. Unlike phage , the minimal necessary flanking sequences 29 
for the attB site do not appear to be equal in size with a total length between 62 and 93 bp. 30 
Furthermore, we identified that the Φ24B integrase does not require IHF to drive the integration and 31 
recombination process. Understanding how this unusual Stx phage integrase works may enable 32 
exploitation of its promiscuous nature in the context of genetic engineering.  33 
  
2 Introduction 34 
Shigatoxigenic Escherichia coli (STEC) emerged in the early 1980s as the causal agents of a variety 35 
of clinical symptoms and sequelae ranging from mild diarrhea through to life threatening conditions 36 
such as hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP)(Fogg et 37 
al, 2011; Paton & Paton, 1998). The key virulence factor of STEC is the expression of Shiga toxin 38 
(Stx), which is an AB5 toxin encoded on a small operon comprising 2 genes. The stx genes are 39 
acquired following infection with an Stx phage (O'Brien et al, 1984), a temperate lambdoid phage 40 
that carry stx genes within the late gene region of its genome (Smith et al, 2012; Unkmeir & Schmidt, 41 
2000). Stx phages are members of the lambdoid group of phages which have a common genomic 42 
organization and content. The behavior of the archetypal member of this group, phage , underpins 43 
most of what we understand about lambdoid phage biology. The expression of the stx genes is linked 44 
to the bacteriophage’s lytic replication cycle, which subverts the host cell’s resources in order to 45 
produce more phage particles (Allison, 2007; Unkmeir & Schmidt, 2000; Wagner et al, 2002). 46 
However, not all bacteriophage infections result in the lysis of the host cell. DNA from most , 47 
temperate phages, including phage  and Stx phages, can, alternatively, become integrated in the host 48 
genome, becoming a prophage (Madsen et al, 1999; Saunders et al, 2001) or in a few other phages 49 
survive in the cell as a replicating plasmid (Łobocka et al, 2004). For those phage destined to become 50 
integrated, the incoming phage produces a site-specific recombinase enzyme that directs phage 51 
recombination within the bacterial genome. For lambdoid phages, this recombinase enzyme is known 52 
as integrase (Groth & Calos, 2004). 53 
 54 
The integrase from phage  (Int) is a tyrosine, site-specific recombinase enzyme that drives 55 
recombination between two specific, complimentary DNA sequences, the attP (250 bp) site (Biswas 56 
et al, 2005; Hsu et al, 1980; Mizuuchi & Mizuuchi, 1980) located on the phage genome and the attB 57 
site (21 bp) (Mizuuchi & Mizuuchi, 1985) located within the bacterial genome (Fogg et al, 2014; 58 
Mizuuchi & Mizuuchi, 1980). The attP is composed of two integrase binding sites (P and P’) and 59 
the core-binding site (COC’). The attB site comprises a central overlap region, known also as O (7 60 
bp) which is flanked by imperfect, inverted repeats, B (7 bp) and B’(7 bp) (Mizuuchi & Mizuuchi, 61 
1985). Though Int is the only phage-encoded protein needed for phage  integration within the host 62 
genome (Fogg et al, 2011), most tyrosine integrases do not act autonomously and require the help of 63 
a bacterial encoded accessory factor (Groth & Calos, 2004). The host-encoded accessory factor 64 
required by Int is integration host factor IHF, which works as an accessory protein, enhancing the 65 
enzymatic activity Int. IHF, a ~ 21.8 kDa heterodimeric DNA-binding protein, is composed of two 66 
monomers:  (~11 kDa) and  (~9.5 kDa) (Azam & Ishihama, 1999; Kikuchi & Nash, 1978; Sanyal 67 
et al, 2014), encoded by himA and himD genes, respectively (Yang & Nash, 1995). IHF interacts with 68 
three specific DNA sequences surrounding the attP site in order to maintain a DNA topography that 69 
enables the action of the now active homotetrameric Int enzyme (Sugimura & Crothers, 2006). IHF 70 
binding sites are around 30 - 35 bp in size and are composed of at least two domains: the 3’ region 71 
and the 5’ region. Unlike the 3’ region, the 5’ region is random in most cases. Alignment among IHF 72 
binding sequences within an attL population library showed that the 3’ region is where IHF binds 73 
strongly and specifically due to the presence of a 13 bp consensus sequence (WATCAANNNNTTR). 74 
The 5’ sequences are all simply AT rich and lack any obvious sequence patterns (Goodman et al, 75 
1999).  76 
 77 
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The crossover regions of attB and attP interact with each other through sequence homology 78 
(Weisberg et al, 1983) aided by protein-DNA interactions between IHF and specific sites in attP that 79 
lie between COC and P (Frumerie et al, 2008). The Int, attB, attP, and IHF complex then allows 80 
Int to sequentially exchange crossover regions of the attB and attP sites. Int possesses a high 81 
binding affinity for the P and P’ sites of attP and low affinity binding to the COC’ site of attP (Groth 82 
& Calos, 2004). Int’s recombination mechanism takes the form of a tetrad complex of four Int 83 
monomers; each monomer binding to the DNA substrate at the same time (Rajeev et al, 2009). The 84 
reaction is started by the Int N-terminal domain of each monomer bound to the P and P’ in attP 85 
(Biswas et al, 2005). The Int C-terminal domains (core binding and catalytic domains) recognize and 86 
bind to the complementary crossover sequences (COC’ in the attP and BOB’ in the attB ) regions in 87 
a square planer formation, promoting DNA recombination (Van Duyne, 2005). One strand is cut by 88 
the first two active Int monomers at both the attB and attP sites. The next step involves DNA strand 89 
exchange and a ligation reaction between one strand from each site, reforming the integrity of the 90 
DNA strand. This strand exchange generates a Holliday junction (HJ) intermediate (Biswas et al, 91 
2005). The HJ is resolved when the second pair of integrase monomers carry out the second DNA cut 92 
followed by the second DNA strand exchange and ligation, completing the integration event (Hsu & 93 
Landy, 1984). This recombination description is based on the “branch migration” model (Weisberg et 94 
al, 1983). DNA recombination results in the creation of two new, unique, hybrid sites, attL and 95 
attR, differing in sequence from either attB or attP (Stark et al, 1992). Once this reaction has 96 
occurred, expression of the site-specific recombinase is silenced by the action of  repressor (CI) 97 
(Calendar, 2006; Serra-Moreno et al, 2008). 98 
 99 
The lambdoid bacteriophage Φ24B is a Shiga toxin-encoding, temperate phage currently classified in 100 
the species Escherichia virus 24B, the genus Traversvirus, the subfamily Sepvirinae and the family 101 
Podoviridae. It has been well characterized with respect to host range (James et al, 2001), host 102 
receptor (Smith et al, 2007a), survival studies (Johannessen et al, 2005), comparative genetic 103 
composition (Smith et al, 2012; Smith et al, 2007b), induction signals (Bloch et al, 2015; Fogg et al, 104 
2012; James et al, 2001; Licznerska et al, 2016), and DNA replication proficiency (Kozłowska et al, 105 
2017; Nejman et al, 2011).  The integrase of Φ24B and its cognate recombination directionality factor 106 
(RDF) have been identified and their expression characterized (Fogg et al, 2007; Fogg et al, 2011; 107 
Fogg et al, 2012). The Φ24B int gene (EF397940.1) encodes a product (IntΦ24B) of ~45 kDa whose 108 
expression is not controlled by the phage repressor, but is expressed constitutively (Fogg et al, 2011). 109 
This integrase, IntΦ24B, belongs to the tyrosine recombinase family (Balding et al, 2005; Esposito & 110 
Scocca, 1997; Fogg et al, 2007). Though various integration sites for the IntΦ24B have been identified 111 
(Fogg et al, 2007), and it is understood how prophage induction can be controlled with a 112 
constitutively expressed integrase and an inducible RDF (Fogg et al, 2011), little is known about the 113 
exact sequences and accessory factors outside the integrase and core crossover sites (Fogg et al, 114 
2007) that are necessary to drive integration. In this study, we establish working protocols for both in 115 
vitro and in situ integration assays to determine the minimal required sequence lengths of both attP 116 
and attB to support integration at the primary integration site in the E. coli chromosome. We also 117 
investigate the role of the bacterial-encoded integration host factor (IHF) in prophage integration. 118 
3 Results  119 
Setting up an in vitro IntΦ24B assay 120 
Φ24B is a member of the lambdoid group of phages based on its genome sequence and genomic 121 
context (Smith et al, 2012; Smith et al, 2007b). It was therefore reasonable to assume that IntΦ24B 122 
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would function in a similar fashion to Int. To test this hypothesis, an in vitro assay was designed. 123 
Such an assay required at least 4 components: purified IHF, purified IntΦ24B and the DNA sequences 124 
attPΦ24B, and attBΦ24B. Conditions for the induction and purification of recombinant IHF have been 125 
previously published (Frumerie et al, 2005). However, the initial attempts to purify the recombinant 126 
IHF did not result in the purification of both subunits of the heterodimer. Therefore, the expression 127 
plasmid pEE2003 (Frumerie et al, 2005) was recovered and transformed into a different E. coli 128 
background, strain BL21, which enabled the purification of both IHF subunits (Fig.1A). Purified 129 
recombinant IntΦ24B was obtained from the previously described construct pΦ24B-int (Fogg et al, 130 
2011), which encodes an active, recombinant integrase with a histidine tag, inducible with arabinose 131 
(Fig.1B). Though the exact lengths of the attB and attP sequences needed to support recombination 132 
were unknown, it had been demonstrated that only attB and attP sites of 600 bp were sufficient to 133 
enable recombination in situ (Fogg et al, 2011). Therefore, different lengths of both attP and attB 134 
sequences were produced (Supplementary Tables 1 & 2) and cloned into pCR2.1 (Supplementary 135 
Table 1). The identity of transformants carrying potential attB constructs of 100, 200, 300, 400 or 136 
600 bp in length (Fogg et al, 2007) or similarly designed attP constructs (100, 200, 300, 400 or 600 137 
bp) were confirmed by PCR using M13 F/R primers and the introduction of potential point mutations 138 
ruled out by Sanger sequencing.  139 
 140 
Before mixing the recombinant proteins with the DNA constructs, the absence of nucleases in the 141 
recombinant protein preparations was confirmed by incubating either IHF or IntΦ24B with 100 ng of 142 
pCR-Φ24B-attP600 (Fig. 2A). The in vitro integration assays were then set up to determine if Φ24B 143 
integrase was able to promote recombination between attP and attB. This assay was repeated 144 
multiple times with various reagent mixtures using different buffers, with or without the addition of 145 
crude cell lysate from E. coli TOP10 cells. Recombination events during the in vitro assays occurred 146 
only under very specific conditions: linearized pCR2.1-Φ24B-attB600, and supercoiled pCR2.1-Φ24B-147 
attP600 in the presence of Int Φ24B and a crude cell extract of E. coli strain TOP10 (Fig. 2B & C). The 148 
identity of the recombination product was confirmed by PCR using M13 F/R or attRL F/R 149 
(attP150F/attBR) oligonucleotide primers (Supplementary Table 2) (Fig. 2D), and their identity was 150 
verified by Sanger sequencing. It was not clear from these results if the recombinant IHF protein was 151 
active or not or whether the assay conditions were not optimized to support recombination activity. 152 
Consequently, an in situ assay already demonstrated to work reliably (Fogg et al, 2011) was adapted 153 
to better characterize the requirements of IntΦ24B. 154 
 155 
Characterization of IntΦ24B requirements using an in situ assay 156 
The in situ assay required that the cell hosting the recombination events was capable of stable 157 
maintenance of 3 different plasmids (Fig. 3A). The plasmid pΦ24B-int replicates with an origin of 158 
replication from pBR322, which was also the same origin of replication supporting replication of the 159 
plasmids carrying attB and attP sites (Supplementary Table 1) used in the in vitro recombination 160 
assay. To avoid plasmid incompatibility issues in a single E. coli cell, all attB sequence variants were 161 
subcloned into pACYCDuet-1 (Fig. 3C), which carries a p15A origin of replication. All attP 162 
sequence variants were subcloned into pCDFDuet-1 (Fig. 3B), which carries an origin of 163 
replication unrelated to the other two plasmids (Supplementary Table 1). The appropriate plasmids 164 
were transformed into E. coli TOP10 cells (Supplementary Table 1), Int Φ24B expression was induced 165 
with arabinose, and integration events were identified by determining the existence of the large 166 
hybrid pΦ24B-attRL plasmid (Fig. 3A). The integration products were all confirmed by Sanger 167 
sequencing. The experiments were run with two replicates. The minimum attP sequence necessary to 168 
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support phage genome integration inside E. coli genome comprised between 350 bp and 427 bp, with 169 
almost equal integrase binding sites (P and P’) site lengths (Fig. 3B).  170 
 171 
The sequences required by IntΦ24B for activity with regards to attB were studied in a similar fashion. 172 
The large hybrid pΦ24B -attRL plasmid products (Fig. 3A) were identified indicating attP and attB 173 
recombination. The minimal attB sequence that could support phage integration comprised between 174 
93 bp and 62bp (Fig 3C). The product identities were confirmed by Sanger sequencing. The attB site 175 
utilized by IntΦ24B is much longer than the 21 bp attB  site utilized by Int (Mizuuchi & Mizuuchi, 176 
1985).  177 
The role of IHF in IntΦ24B activity 178 
To test the importance of IHF in promoting the activity of Int Φ24B to drive integration of its attP into 179 
the attB in the E. coli genome, the E. coli strain TOP10 used in the in situ recombination assay was 180 
replaced with the E. coli strain JW1702-1 (Baba et al, 2006) in which the himA gene has been 181 
deleted. A deletion of one of the genes involved in the production of the IHF heterodimer ablates the 182 
production of an active IHF. The introduction of pΦ24B-attB288-288, pΦ24B-attP600 and pΦ24B-int  183 
(Supplementary Table 1) into strain JW1702 resulted in the production of a large chimeric DNA 184 
product only after the expression of the IntΦ24B was induced by the addition of arabinose (data not 185 
shown). This demonstrated that integration could occur in the absence of IHF. However, the 186 
requirement of the crude cell lysate in the in vitro recombination assay does suggest that another, as 187 
of yet unidentified, host-encoded protein is required for Int Φ24B activity.  188 
 189 
4 Discussion 190 
Escherichia phage  is generally used as a textbook illustration of temperate phage behavior. Our 191 
research shows that temperate phage integration, including the presence of host factors and 192 
recognition sites, is not generalizable from , in particular for the Shiga-toxin encoding phage Φ24B. 193 
This study sought to better understand how Φ24B mediates integration and to define the factors 194 
required for IntΦ24B to function. We know that this integrase exhibits some degree of promiscuity, 195 
being able to utilize multiple different sequences in the E. coli genome (Fogg et al, 2007), so 196 
understanding how this enzyme functions and what factors are necessary for its function could lead 197 
to potential biotechnological applications. This knowledge also has important implications for 198 
understanding the dissemination of Stx phages and their ability to expand the diversity of Shiga toxin 199 
producing pathogens (Allison, 2007; Grotiuz et al, 2006; Muniesa et al, 2012).  200 
 201 
Previous studies have demonstrated that experimental parameters required for various integrases in in 202 
vitro recombination assays are not uniform. In the case of recombination catalyzed by the 203 
bacteriophage P2-encoded integrase, a tyrosine recombinase, integration requires 2 att sequences, the 204 
phage integrase and a bacterial IHF (Sylwan et al, 2010), a phenomenon not uncommon across 205 
tyrosine recombinases (Groth & Calos, 2004). However, there are tyrosine recombinases like Cre, 206 
encoded by bacteriophage P1, that function without accessory proteins (Groth & Calos, 2004). Due 207 
to our lack of controls for the activity of recombinant IHF and IntΦ24B , the only interpretable 208 
information obtained was that in vitro, recombination worked best if attB was linearized and attP was 209 
not (Fig. 2) and that proteins in a crude cell lysate were essential for recombination. Utilization of a 210 
linearized target for phage integration has been described previously, for the integrase encoded by the 211 
bacteriophage P2 (Frumerie et al, 2008), however IntP2 and IntΦ24B have unrelated integrase box I and 212 
box II sites (Balding et al, 2005; Smith et al, 2007b). To better characterize the requirements of 213 
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IntΦ24B, further experiments were run using a proven in situ assay (Fogg et al, 2011). The in situ assay 214 
does not allow the parameters of the recombination events to be strictly controlled in terms of the 215 
concentrations and ratios of DNA, protein, enzymes and reaction buffer content, but has been used to 216 
reliably detect recombination events (Bliska & Cozzarelli, 1987; Fogg et al, 2011; McCulloch et al, 217 
1994; Rajeev et al, 2009). 218 
 219 
Altering our approach to characterize IntΦ24B using an in situ assay enabled us to determine the 220 
minimal length of the attP sequence capable of supporting integration. The P’ side of attP is ~80 bp 221 
in length, while the P side possesses the integrase binding site and is larger, ~140 bp (Goodman et al, 222 
1999; Groth & Calos, 2004; Sylwan et al, 2010). A 600 bp DNA fragment harboring the attPΦ24B in 223 
its center had been shown previously (Fogg et al, 2011) to support integration, so this fragment was 224 
used and subsequently shortened to examine the impact of shorter sequence lengths on recombination 225 
(Fig. 4). In order to examine whether the P and P’ arms flanking the central recombination core need 226 
to be equal sizes or not, in situ assays were run using pΦ24B-attP427, pΦ24B-attP350, pΦ24B-attP237 and 227 
pΦ24B-attP140 (Fig 4). The smallest attPΦ24B construct supporting recombination was pΦ24B-attP427. 228 
This is considerably larger than the attP site with attPΦ24B P and P’ arm lengths more equal in size.  229 
 230 
The in situ recombination assay also enabled determination of the minimal attB sequence 231 
requirements. Tyrosine site-specific recombinases have complex binding sites, however the attB site 232 
is usually less complex than the attP site. The site attB, for example, is only 21 bp in length, 7 bp 233 
serving as the central crossover core sequence that interacts with the attP site (Mizuuchi et al, 1981) 234 
and 7 bp on either side serving as the B and B’ arms. Nevertheless, according to our results, attBΦ24B 235 
site composition is not that simple. The shortest sequence tested that could support recombination 236 
was 93 bp long (Fig. 4), comprising of a 49 bp B arm followed, the 24 bp crossover site and a 20 bp 237 
long B’ arm. This sequence is very long compared to other characterized tyrosine recombinase attB 238 
sites (Kolot et al, 1999; Lorbach et al, 2000). Some of the larger attB sequences characterized for 239 
members of the tyrosine recombinase family, e.g. FLP and Cre, require an attB sequence ~50 bp 240 
(Abremski & Hoess, 1984; Andrews et al, 1985), while the 62 bp attBΦ24B comprising of an 18 bp- B 241 
arm and a 20 bp B’arm could not support recombination. The smallest attBΦ24B site supporting 242 
recombination of an asymmetrical site.  This would be very unusual for an attB site as most B and B’ 243 
arms are the same size (Kolot et al, 1999; Lorbach et al, 2000), but the resolution of our strategy did 244 
not allow us to definitively determine whether the B arm is actually larger than the B’ arm, though it 245 
is definitely unusual with regard to its length. 246 
 247 
While bacterial-encoded IHF is necessary for the function of most tyrosine site-specific recombinase 248 
proteins (Fogg et al, 2014), there are integrases that do not require IHF, e.g. the integrase from the 249 
bacteriophage P22 of Salmonella enterica serovar Typhimurium can drive recombination in the 250 
absence of IHF protein, though IHF can enhance the binding of IntP22 to attPP22 (Smith-Mungo et al, 251 
1994). Data from two different assays have demonstrated that IntΦ24B functions in the absence of IHF. 252 
Firstly, when the assay was performed in situ using the JW1702-1 strain of E. coli that cannot 253 
produce IHF due to the interruption of himA (encodes the IhfA subunit), recombination events were 254 
detected in an indistinguishable manner from those occurring in the TOP10 E. coli background. In 255 
line with data from the in vitro recombination assay, it became clear that recombinant IHF activity 256 
was not required, but that some other unknown factor(s) present in the E. coli crude protein extract 257 
were important. It is highly probable that the reason the in vitro assay did not work well under the 258 
conditions tested here was not because of the failure to produce biologically active recombinant 259 
proteins, but was due to the absence of at least one other currently undefined cellular 260 
factor/component. 261 




The ability of IntΦ24B to drive phage genome integration inside the E. coli cell can have a profound 263 
impact on bacterial virulence (Allison, 2007; Fogg et al, 2012). The Stx phage integration results in a 264 
cell that, upon clonal expansion, generates numerous progeny that can produce Shiga toxin, the 265 
primary virulence factor of EHEC (Paton & Paton, 1998) which are a continuing threat to food safety 266 
and public health worldwide. Therefore, it is important to understand how this integrase functions 267 
and to identify precisely what is required for it to drive DNA recombination. Each Stx phage 268 
characterized to date carries a single integrase gene, and though there are many variants of integrase 269 
associated with Stx phages (Smith et al, 2012), IntΦ24B is particularly promiscuous being able to 270 
integrate efficiently into more than one location in the E. coli genome (Fogg et al, 2007). Thus far, 271 
only the primary attBΦ24B has been characterized; upon infection, Φ24B attempts to use this site first 272 
and will only use a secondary site if the primary site is occupied (Fogg et al, 2007). Comparison here 273 
(data not shown) of the now better defined primary attBΦ24B with the other sequences surrounding the 274 
secondary attB sites (Fogg et al, 2007) in the E. coli chromosome has not revealed any shared 275 
homologies beyond those identified by Fogg et al. (2007). More work is needed to identify the E. 276 
coli-encoded factors used by IntΦ24B, how the integrase interacts with the secondary attB sites and 277 
what sequences within attP and attB actually support integrase binding. The work presented here 278 
builds upon our knowledge of the DNA sequences required for integration.  We have demonstrated 279 
that the attB sequence needs to be linearized for integration to begin, and we have demonstrated that 280 




5 Materials and Methods 285 
Strains, plasmids, media, buffers and oligonucleotides 286 
All bacterial strains and plasmid constructs used in this study are described in appropriate detail in 287 
Supplementary Table 1. All oligonucleotide primers used in this study are listed in Supplementary 288 
Table 2. 289 
Protein Overexpression  290 
In order to produce recombinant IHF for the in vitro recombination assay, an overnight culture (1 291 
mL) of E. coli TOP10 cells (Supplementary Table 1) harboring one of the two the histidine-tagged 292 
expression constructs, pEE2003 (kindly donated by E. Haggard-Ljungquist) or p24B-int, or BL21 293 
cells harbouring pEE2003 was used to inoculate 10 mL of LB broth (3.7% (w/v) Luria Bertani Agar 294 
(Merck KGaA, Darmstadt, Germany) containing 100 g/mL ampicillin that was incubated at 37℃ 295 
with shaking at 200 rpm until the OD600 reached 0.5-0.7. A sample (1 mL) was immediately 296 
harvested from the culture, and the cells recovered by centrifugation at 10,000 x g for 20-30 min, at 297 
4℃ and resuspended in 50 𝜇l of Tricine Sample Buffer (0.1 M Tris-Cl, pH 6.8; 24% (v/v) glycerol; 298 
8% (w/v) SDS, 3.1% (w/v) DTT; 0.02% (w/v) Coomassie Blue R250). The resuspended cells were 299 
frozen at -20℃ for later use (non-induced control cells). Expression of the recombinant histidine 300 
tagged protein was induced from the remaining 9 mL of culture using either 0.02% w/v L-arabinose 301 
or 5 mM IPTG for recombinant histidine tagged IntΦ24B or IHF, respectively. The induced culture was 302 
further incubated at 37℃ with shaking at 200 r.p.m. for 3-4 hrs. The culture was then placed on ice 303 
and a sample (1 mL) was taken. The cells in that 1 mL were harvested by centrifugation at 10,000 x g 304 
for 20-30 min at 4℃, resuspended in 100 μl of Tricine Sample Buffer, and frozen at -20℃ until 305 
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needed (induced control). The rest of cells were harvested by centrifugation at 10,000 x g for 20-30 306 
min at 4℃. The resultant pellet was resuspended carefully in 5 ml of ice-cold lysis buffer (50 mM 307 
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8) for purification of the His-tagged protein under 308 
native conditions, according the instructions of QIAGEN’s QIAexpressionist handbook (W. Sussex, 309 
U.K.). Using a MSE ultrasonic disintegrator (Henderson Biomedical, UK) with a microtip probe, the 310 
sample was treated 6-8 times with 10 seconds pulses at 200-300 Watts and an amplitude of 70 𝜇𝑚. 311 
The lysate was kept on ice at all times, until it was subjected to centrifugation at 10,000 x g for 20-30 312 
min at 4C. The supernatant was harvested (crude cell extract A, soluble proteins) and stored on ice. 313 
The resultant pellet was resuspended in 5 ml lysis buffer (crude extract B, insoluble proteins). Crude 314 
extracts A and B (5 μl, each), were mixed with 5 μl of Tricine Sample Buffer (62.5 mM Tris-HCl, pH 315 
6.8; 2.5 % SDS; 0.002 % Bromophenol Blue; 0.7135 M (5%) β-mercaptoethanol; 10 % glycerol). 316 
These samples, along with the noninduced and induced control samples, were heated to 95℃ for 5 317 
min. The samples were then centrifuged at 15,000 x g for 1 min, before being subjected to SDS-318 
PAGE. 319 
Protein purification  320 
Histidine-tagged proteins were purified using the HisTrap (GE healthcare life sciences, Chicago, 321 
USA) protein purification 1ml column utilizing Ni-NTA technology. The column was first washed 322 
with water (5 x void volume), before equilibration with an equal volume of lysis buffer. The column 323 
was loaded with crude extract A (soluble proteins and then washed with several washing buffers (50 324 
mM NaH2PO4, 300 mM NaCl, pH 8) comprised of varying imidazole concentrations (20, 30, 40, 50 325 
and 60 mM), and finally treated with elution buffer (50 mM NaH2PO4, 300 mM NaCl, pH 8 with 250 326 
mM imidazole). The volume of washing buffers and elution buffer used were 5 times the column 327 
void volume. The washes and eluates were collected in graded test tubes. The column was then 328 
washed with lysis buffer, water and finally filled with 20% ethanol for storage at 4 °C or subsequent 329 
reuse. Protein samples were dialyzed to remove all imidazole using dialysis tubing (Medicell, 330 
London, UK) with a pore-size capable of retaining proteins of 12-14 kDa and then concentrated 331 
using Vivaspin 20 tubes (5 kDa) (GE Healthcare, Buckinghamshire, UK). The concentration of each 332 
protein was measured using the Pierce BCA Protein Assay Kit according to the manufacturer’s 333 
instructions. A sample of 15 µl from each elution tube was mixed with 5ul of Tricine Sample Buffer, 334 
heated to 95℃ for 5 min and loaded onto an SDS-PAGE gel.  335 
 336 
SDS PAGE 337 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis, SDS-PAGE (Laemmli, 1970), was 338 
performed to examine protein preparations using the Mini-Protean 3 Unit (Bio Rad, Serial NO 67S). 339 
The vertical running gel was 0.75 mm thick and composed of a bottom Separating gel (1 ml water; 340 
1.25 ml 3M Tris-HCl/SDS, pH 8.4; 1.12 ml 40% acrylamide; 0.37 ml glycerol; 5 𝜇l 30% APS; and 5 341 
𝜇l TEMED), and an upper Stacking gel (2.03 ml water; 0.77 ml 3M Tris-HCl/SDS, pH 8.4; 0.31 ml 342 
40% acrylamide; 5 𝜇l 30% APS; and 5 𝜇l TEMED). A 20 𝜇l-sized well forming comb was used to 343 
cover the top of the stacking gel until it was polymerized. The polymerized gel was placed into the 344 
electrophoresis tank, with appropriate cathode (0.5 M Tris base, pH8.45) and anode (1 M Tricine, pH 345 
8.3 with 2% SDS) buffers. Samples (15 𝜇l sample and 5 𝜇l Tricine sample buffer) were loaded in the 346 
gel wells using a pre-stained 10-250 kD molecular weight marker (BioRad) in the outer wells. 347 
electrophoresis was performed at 150 V for 30 min. The unit was dismantled, and the gel placed in 348 
Coomassie Blue Stain (2% (w/v) Coomassie Blue R250 in 45% (v/v) methanol and 10% (v/v/) 349 
glacial acetic acid) with gentle agitation for 30 min. The gel was destained with several exchanges of 350 
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Coomassie Blue Destain (45% (v/v) methanol and 10% (v/v/) glacial acetic acid ) until a clear gel 351 
background was obtained. 352 
Cloning of bacterial and phage attachment sites in pCR2.1 353 
The attB core sequence (Fogg et al, 2007) and either 100 bp, 200 bp, 300 bp, 400 bp or 600 bp of its 354 
flanking sequence were amplified from the MC1061 E coli genome using attB100 F/R, attB 200 F/R, 355 
attB300 F/R attB400 F/R or attB 600F/R oligonucleotide primers, respectively. 356 
At the same time, the attP core sequence (Fogg et al, 2007) and either 100 bp, 200 bp, 300 bp, 400 bp 357 
or 600 pb of flanking sequence was amplified from the Φ24B genome using attP140 F/R, attP200 358 
F/R attP300 F/R attP400 F/R or attP 600F/R primers, respectively. Amplification parameters 359 
involved an initial denaturation period of 2 min at 95C followed by 30 cycles of denaturation for 10 360 
sec. at 95C, annealing for 10 sec. at 50C, extension for 30 sec. at 72C, followed by a final 361 
extension period for 2 min. at 72C. Amplification reactions used MyTaq (Bioline) DNA 362 
polymerase according to the manufacturer’s recommendations. Each of the attB or attP sequences 363 
was cloned, separately, into the pCR2.1 cloning vector (Invitrogen), according to manufacturer’s 364 
guidelines. The attB and attP pCR2.1 constructs, were all individually transformed into chemically 365 
competent TOP10 cells. The transformants were cultured overnight on LB agar plates containing 366 
ampicillin (100 𝜇g/mL) and kanamycin (50 𝜇g/mL). The identities of the desired transformants were 367 
confirmed by colony PCR using primers (M13 F/R) flanking the multiple cloning site of the pCR2.1 368 
with the amplification parameters described earlier before they were sent for Sanger sequencing. 369 
Freezer stocks were made from each positive transformant and stored at -80 °C. 370 
 371 
In Vitro Recombination Assay 372 
In order to prepare a crude cellular protein extract, cells from an overnight TOP10 culture were 373 
harvested by centrifugation for 20-30 min at 10,000 x g at 4℃. The resultant pellet was resuspended 374 
carefully in 5 ml of ice-cold lysis buffer. The cells were lysed as described above. The lysate was 375 
kept on ice at all times, until it was subjected to centrifugation for 20-30 min at 10,000g at 4C. Total 376 
protein in the supernatant was quantified as described above and used as a crude protein extract. 377 
 378 
Recombination assays were always performed in duplicate using either coiled pattP plasmid 379 
(pCR2.1-𝛷24B-attP100, 200, 300, 400 or 600, Supplementary Table 1) with coiled pattB plasmid (pCR2.1-380 
𝛷24B-attB100. 200, 300, 400 or 600, Supplementary Table 1), coiled pattP plasmid with linear pattB plasmid 381 
or linear pattP plasmid with coiled pattB plasmid. Approximately 500 ng of each DNA target species 382 
were incubated with or without combinations of recombinant IHF (100 ng ~90% purity as 383 
determined by SDS-PAGE), recombinant Int24B (200 ng 90% purity as determined by SDS-PAGE) 384 
and/or E. coli derived crude protein extracts (500 ng protein) in a final reaction volume of 50 𝜇l. 385 
pCR2.1 plasmids harboring pattP or pattB sequences were linearized by the restriction enzyme 386 
BamH I. Two types of buffer were utilized in these reactions: Buffer 1 ( 20 mM Tris, pH 7.5, 100 387 
mM NaCl, 1% glycerol, 0.1 mM EDTA (Thorpe & Smith, 1998)) or Buffer 2 (50 mM Tris-Cl, pH 388 
7.8, 60 mM KCl, 250 µg of BSA, 0.5 mM EDTA, 10% glycerol 5 mM spermidine in a final reaction 389 
volume of 15 µl (Goodman et al, 1999)). The reactions were incubated for 6 or 24 hours at 37°C and 390 
stopped by separating the resulting DNA molecules by TAE agarose gel electrophoresis. Any band of 391 
the expected recombinant size was excised from the gel, extracted using an Isolate PCR and Gel kit 392 
from Bioline, and used as PCR template. If recombination occurred, a unique attRL product could be 393 
amplified using attRL F/R primers and the amplification parameters described above. The identity of 394 
the amplified product was confirmed by Sanger sequencing (GATC Biotech AG [Germany]).  395 
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Subcloning attB and attP sites into compatible plasmids 396 
The plasmid construct, pCR-Φ24B-attP600 harboring the attP core and 600 bp of flanking sequence, 397 
was purified from E. coli TOP10 strain. The attP fragment was recovered using BamH I and Xho I 398 
restriction endonuclease enzymes. The same pair of enzymes was used to cut the high copy number 399 
plasmid, pCDF-Duet. After endonuclease inactivation, by incubation at 65 °C for 20 minutes, the 400 
digestion products were each purified on a TAE agarose gel and recovered using the Isolate PCR and 401 
Gel kit (Bioline, London, U.K.). The attP sequence was ligated into pCDF-Duet to form pΦ24B-402 
attP600), before it was transformed into competent TOP10 E. coli cells. In parallel pCR-Φ24B-attB600 403 
harboring the attB core and 600 bp of flanking sequence, and the medium copy number pACYC-404 
Duet, a plasmid compatible with pCDF-Duet, were also digested using the same endonuclease 405 
enzymes (BamH I and Xho I) and the products cloned together as described above to produce pΦ24B-406 
attB600 before it was transformed into fresh TOP10 competent cells. This cloning strategy was used 407 
repeatedly to produced constructs harboring variously sized attB and attP sequences. 408 
In situ recombination assay  409 
All in situ recombination assays were performed inside One Shot TOP10 E coli cells (Supplementary 410 
Table 1). Each required plasmid transformed sequentially into these cells until all required, 411 
compatible plasmids for each assay were in one E coli host cell. An appropriate amount of LB broth, 412 
supplemented with the plasmid’s resistance antibiotics at their specific concentrations, was 413 
inoculated with 1 ml of an overnight culture of cells harboring the compatible plasmids. This culture 414 
was incubated at 37°C with shaking at 200 rpm until the OD600 0.5-0.8 was reached. Expression of 415 
the integrase protein (Int) was induced by the addition of L-Arabinose to a final concentration of 416 
0.02% w/v. The cultures were incubated for an additional three hours at same incubation temperature. 417 
Finally, from each assay flask, 5 ml samples were taken and all plasmid DNA present was extracted 418 
from the cells in the samples. Recombination events during the in situ recombination assays were 419 
only determined to have occurred when the following three criteria were met: 1) a PCR reaction 420 
using attRL F/R primers resulted in the production of DNA product, 2) TAE agarose gel 421 
electrophoresis verified the size of the amplification product and 3) Sanger sequencing of the PCR 422 
products confirmed the identity of the hybrid site. All these assays where performed along with a 423 
negative control comprised of a sample that was not induced with arabinose so that no Int was 424 
produced. 425 
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12 Figure Legends 603 
Figure 1. Purification of recombinant proteins. Panel A, Production of dimeric IHF from the 604 
construct pEE2003. E. coli strain BL21 carrying the plasmid pEE203 (Supplementary Table 1) was 605 
cultured in 10 mL of LB broth and overexpression was induced with 5 mM IPTG.  After 3-4 hours 606 
the cells were harvested, and the proteins purified using a HisTrap (1ml) column (GE Healthcare Life 607 
Sciences). The various steps of this process were analysed on an SDS-PAGE gel.  Lanes: MW, 608 
prestained molecular weight markers (2-250 kD) (BioRad); 1, whole cell lysate; 2, Ni-column flow 609 
through; 3-5, column washes; 6, IHF in 60 mM imidazole washing buffer. Arrows indicate the 11.3 610 
kDa his-tagged IhfA subunit and the co-purifying 10.6 kDa IhfB subunit. Panel B, Production and 611 
Purification of recombinant Int Φ24B. E. coli strain MC1061 carrying the plasmid pΦ24B-int 612 
(Supplementary Table 1) was cultured in 10 mL of LB broth and overexpression was induced with L-613 
Arabinose.  After 3-4 hours the cells were harvested, and the proteins purified using a HisTrap (1ml) 614 
column (GE Healthcare Life Sciences). The various steps of this process were analysed on an SDS-615 
PAGE gel. Lanes: MW, pre-stained molecular weight markers (10-250 kDa; BioRad); 1, whole cell 616 
lysate; 2, Ni-column flow through; 3-5, column washes; 6, Integrase in 60 mM imidazole. The arrow 617 
indicates the purified 45 kDa monomer of IntΦ24B. 618 
 619 
Figure 2. Data from the in vitro recombination assay. Panel A, Demonstration that the 620 
recombinant IHF and Integrase preparations did not contain nucleases. Purified recombinant 621 
IHF and IntΦ24B were incubated with pCR2.1- Φ24B-attP600 to monitor these protein preparations for 622 
possible co-purifying nucleases.  Lanes: MW, HyperLadder 1 kb (Bioline); 1, 100 ng pCR2.1- 623 
Φ24B-attP600; 2 and 3, 100 ng pCR2.1- Φ24B-attP600 with 1 µg of IHF or 1 µg of IntΦ24B, 624 
respectively, incubated at 30 °C for 1 hr. No co-purifying nuclease activity was detected. Panels B-625 
C, In vitro recombination assay results using crude protein extracts. B, results after incubation 626 
for 6 hr at 37°C. C, results after incubation for 24 hr at 37°C; Reaction composition by lane numbers: 627 
MW, HyperLadder 1 kb (Bioline)1 & 4 , supercoiled pCR2.1- Φ24B-attP600 only, without crude 628 
protein extract 2 & 5, linearized pCR2.1-Φ24B-attB600 only, without crude protein extract 3 & 6, 629 
linearized pCR2.1-Φ24B-attB600 and supercoiled pCR2.1- Φ24B-attP600 with 500 ng crude protein 630 
extract from TOP10 E. coli; 7, supercoiled pCR2.1- Φ24B-attP600 and linearized pCR2.1-Φ24B-631 
attB600, only. Recombination was only detected in Lanes 3 and 6, by the presence of a 9 kb band. 632 
Panel D, PCR assay of the recombination products. MW, HyperLadder 1 kb (Bioline); 1, 633 
positive control using M13 F/R primers with pCR2.1-attP600 as template; 2, attRL PCR fragment 634 
amplified using M13 F/R primers; 3, attRL PCR fragment amplified using attP150 F/attB R primers; 4. 635 
negative control using M13 F/R primers without template.  636 
 637 
Figure 3. Determining the minimal attP and attB sites utilized by IntΦ24B. Panel A. Diagram 638 
depicting the in situ assay set up, arabinose induction of IntΦ24B expression, and the resulting chimeric 639 
plasmid. Panel B. The design of the various attP constructs (plasmids with nomenclature p𝛷24B-attP, 640 
Suppl Table 1), providing information on the lengths of the P (solid purple) and P’ (hashed purple) 641 
sequences and drawn to scale as they flank the 24 bp central crossover site (green). The detection of 642 
recombination (+) or absence (-) is also indicated. Panel C. The design of the various attB constructs 643 
(plasmids with nomenclature p𝛷24B-attB, Suppl Table 1), providing information on the lengths of the 644 
B (solid blue) and B’ (hashed blue) sequences and drawn to scale as they flank the 24 bp central 645 
crossover site (red). The detection of recombination (+) or absence (-) is also indicated. 646 
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